Avricore Health Announces Late Filing of Annual Financial Statements and Management Cease Trade Order
May 02, 2019 17:22 ET
|
Avricore Health Inc.
Vancouver, May 02, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR) (“Avricore Health” or the “Company”) announced today that as a result of delays in completion of its audit, the Company...
Avricore Health Provides Corporate Update
April 26, 2019 16:01 ET
|
Avricore Health Inc.
Vancouver, April 26, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR) (“Avricore”) announced today the resignation of Ms. Leanne Ratzlaff as Corporate Secretary effective immediately. Due...
Avricore Health Inc. Launches New Website
April 03, 2019 09:00 ET
|
Avricore Health Inc.
Vancouver, April 03, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) As part of Avricore Health’s commitment to providing the most accurate and best...
Avricore Health Inc. Advisory Board Welcomes Mark Zhou
March 19, 2019 08:30 ET
|
Avricore Health Inc.
Vancouver, March 19, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) is very pleased to announce that Mark Zhou will join the company’s Advisory Board and support...
Avricore Health Signs Letter of Intent with Molecular You to Further Enhance the HealthTab Platform with Tests Designed to Ensure Safe Cannabis Use
December 19, 2018 08:30 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) is pleased to announce that it has signed a Letter of Intent (LOI) with...
Avricore Health Signs Letter of Intent to Partner with FoodRocket to Enhance the HealthTab Platform
November 27, 2018 08:00 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) is pleased to announce that it has signed a letter of intent to review...
VANC Pharmaceuticals Inc. Provides Corporate Update
November 01, 2018 19:11 ET
|
VANC Pharmaceuticals
VANCOUVER, British Columbia, Nov. 01, 2018 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (“VANC”) is excited to announce that further to its news release announced October 25, 2018, the Company has...
VANC Pharmaceuticals Inc. Will Change Its Name to Avricore Health Inc. Reflecting Its New Initiatives and Focus
October 25, 2018 07:30 ET
|
VANC Pharmaceuticals
VANCOUVER, B.C., Oct. 25, 2018 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (“VANC”) is pleased to announce that it will seek TSX Venture Exchange (the “TSXV”) approval to change the name of the...
VANC Contracts with Lampyon to Extend its Corozon Educational and Ecommerce Platform with Medical Cannabis Education and New Sales Capabilities
September 27, 2018 08:00 ET
|
VANC Pharmaceuticals
VANCOUVER, B.C., Sept. 27, 2018 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (“VANC”) has contracted with Lampyon Canada Inc. to extend VANC’s proprietary education and ecommerce portal, the...
Philippe Ugnat, LLB joins VANC Pharmaceuticals Inc. as Stratregic Advisor
September 17, 2018 20:32 ET
|
VANC Pharmaceuticals
VANCOUVER, British Columbia, Sept. 17, 2018 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (“VANC” or the “Company”) is pleased to announce the appointment of Philippe Ugnat as Strategic Advisor to...